Unicycive Therapeutics, Inc. (UNCY), Tuesday announced the decision to implement a 1-for-10 reverse split of the issued shares of its common stock, effective June 18, 2025.
The move is intended to increase the bid price of the common stock to enable the company to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.
The company expects to begin trading on a split-adjusted basis when the market opens on June 20, 2025, and will continue to trade on The Nasdaq Capital Market under the symbol "UNCY."
In the pre-market hours, UNCY is moving down 14.35 percent, to $0.64 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.